Cdc42在舌鳞状细胞癌中的表达及临床意义

doi:10.19438/j.cjoms.2018.03.008

中国口腔颌面外科杂志 ›› 2018, Vol. 16 ›› Issue (3): 231-236.doi: 10.19438/j.cjoms.2018.03.008

Cdc42在舌鳞状细胞癌中的表达及临床意义

廖奕翔^1,2，孔庆暖³，郭庆圆²，何宗轩^1,2，仇静²，陈正岗^2,4

1.青岛大学，山东青岛266000；
2.青岛大学附属青岛市市立医院口腔科，3.病理科，山东青岛266000；
4.上海交通大学医学院附属第九人民医院·口腔医学院口腔颌面-头颈肿瘤外科，上海200011

收稿日期:2017-09-18 修回日期:2017-10-20 出版日期:2018-05-20 发布日期:2018-06-12
通讯作者: 陈正岗，E-mail: chenzhg1973@163.com
作者简介:廖奕翔（1991-），男，医师，硕士，E-mail:15898806830@163.com
基金资助:
国家自然科学基金（81372908）

Expression of Cdc42 in tongue squamous cell carcinoma and its clinical significance

LIAO Yi-xiang^1,2, KONG Qing-nuan³, GUO Qing-yuan², HE Zong-xuan^1,2, QIU Jing², CHEN Zheng-gang².

1.Qingdao University. Qingdao 266000;
2.Department of Stomatology,
3.Department of Pathology, Qingdao Municipal Hospital Affiliated to Qingdao University. Qingdao 266000, Shandong Province, China

Received:2017-09-18 Revised:2017-10-20 Online:2018-05-20 Published:2018-06-12

摘要/Abstract

摘要： 目的： 探讨舌鳞癌组织、癌旁组织以及正常舌组织中细胞分裂周期蛋白42（cell division cycle 42，Cdc42）的表达及临床意义。方法： 选择青岛大学附属青岛市市立医院口腔颌面外科2014—2016年手术切除的舌鳞癌原发灶42例，采用免疫组织化学和免疫印迹法检测患者的组织标本（舌鳞癌、癌旁组织和正常舌组织）中Cdc42蛋白的表达水平，并分析其与临床病理参数的相关性。采用SPSS 13.0软件包对相应资料进行t检验与秩和检验。结果： Cdc42蛋白在舌鳞癌以及其癌旁组织中的阳性率分别为80.95%和52.38%，均高于正常舌组织（11.90%），2组间比较差异有统计学意义（P<0.05）。Cdc42蛋白的表达与舌鳞癌的病理分化程度无关（P>0.05），Cdc42蛋白定位在胞核的阳性分度与舌鳞癌的病理分化程度相关（P<0.05）；与患者的年龄、性别无关(P>0.05)；与颈淋巴结转移及舌鳞癌的临床分期呈正相关(P<0.05)。结论： Cdc42蛋白在舌鳞癌组织及癌旁组织中表达增高，与舌鳞癌的发生、发展密切相关。

关键词: 舌, 鳞癌, Cdc42

Abstract: PURPOSE: To investigate expression of cell division cycle 42 (Cdc42) and its clinical significance in tongue squamous cell carcinoma (TSCC). METHODS: Forty-two patients with TSCC were collected and the expression of Cdc42 in tumor, adjacent tissue and normal tissue was detected by immunohistochemistry and Western blot, respectively. The correlation of Cdc42 expression and clinical parameter were analyzed as well. Statistical analysis was performed using t test and rank sum test with SPSS 13.0 software package. RESULTS: The positive rate of Cdc42 in TSCC and adjacent tissue was 80.95% and 52.38%, respectively, which was higher than 11.90% in normal tissue. There was significant difference of Cdc42 expression between tumor, adjacent tissue and normal tissue (P<0.05). Cdc42 protein expression in cases with cervical lymph node metastasis was significantly higher than in cases without cervical lymph node metastasis (P<0.05). The expression of Cdc42 in TSCC had positive relation with clinical stages (P<0.05), but no correlation with pathological grade, age and gender (P>0.05). The expression levels of Cdc42 in nucleus were associated with pathological grade of TSCC. CONCLUSIONS: The results indicated Cdc42 positive expression is higher in TSCC and adjacent tissue. Over-expression of Cdc42 may play an important role in TSCC development and progress.

Key words: Tongue, Squamous cell carcinoma, Cdc42

中图分类号:

R739.86

廖奕翔，孔庆暖，郭庆圆，何宗轩，仇静，陈正岗. Cdc42在舌鳞状细胞癌中的表达及临床意义[J]. 中国口腔颌面外科杂志, 2018, 16(3): 231-236.

LIAO Yi-xiang, KONG Qing-nuan, GUO Qing-yuan, HE Zong-xuan, QIU Jing, CHEN Zheng-gang.. Expression of Cdc42 in tongue squamous cell carcinoma and its clinical significance[J]. China J Oral Maxillofac Surg, 2018, 16(3): 231-236.

参考文献

[1] 郑家伟, 李金忠, 钟来平, 等. 口腔鳞状细胞癌临床流行病学研究现状 [J]. 中国口腔颌面外科杂志, 2007, 5(2): 83-90.
[2] Palasz P, Adamski L, Górska-Chrzastek M, et al. Contemporary diagnostic imaging of oral squamous cell carcinoma-a review of literature [J]. Pol J Radiol, 2017, 82: 193-202.
[3] Rusthoven K, Ballonof A, Raben D, et al. Poor prognosis in patients with stage Ⅰ and Ⅱ oral tongue squamous cell carcinoma [J]. Cancer, 2008, 112(2): 345-351.
[4] Rothenberg SM, Ellisen LW. The molecular pathogenesis of head and neck squamous cell carcinoma[J]. J Clin Invest, 2012, 122(6): 1951-1957.
[5] Fernández-Medarde A, Santos E. Ras in cancer and developmental diseases [J]. Genes Cancer, 2011, 2(3): 344-358.
[6] Gao J, Long B, Wang Z. Role of Notch signaling pathway in pancreatic cancer [J].Am J Cancer Res, 2017, 7(2): 173-186.
[7] Sinha S, Yang W. Cellular signaling for activation of Rho GTPase Cdc42 [J]. Cell Signal, 2008, 20(11): 1927-1934.
[8] Erickson JW, Cerione RA. Multiple roles for Cdc42 in cell regulation [J]. Curr Opin Cell Biol, 2001, 13(2): 153-157.
[9] Jaffe AB, Kaji N, Durgan J, et al. Cdc42 controls spindle orientation to position the apical surface during epithelial morphogenesis [J]. J Cell Biol, 2008, 183(4): 625-633.
[10] Arias-Romero LE, Chernoff J. Targeting Cdc42 in cancer [J]. Expert Opin Ther Targets, 2013, 17(11): 1263-1273.
[11] 张同韩, 刘海潮, 梁玉洁, 等. Notch信号通路分子在舌鳞癌中的表达及意义 [J].华西口腔医学杂志, 2013, 31(3): 303-309.
[12] 邢传平, 刘斌, 董亮. 免疫组织化学标记结果的判断方法 [J]. 中华病理学杂志, 2001, 30(4): 318.
[13] 李江. 口腔癌的临床病理特征与预后 [J]. 中国口腔颌面外科杂志, 2008, 6(1): 17-21.
[14] Lin Y, Zheng Y. Approaches of targeting Rho GTPases in cancer drug discovery [J]. Expert Opin Drug Discov, 2015, 10(9): 991-1010.
[15] 陈正岗, 唐永平, 童磊, 等. 体外RNA干扰RhoA基因对舌癌细胞侵袭的影响 [J]. 华西口腔医学杂志, 2016, 34(2): 183-188.
[16] Wu X, Quondamatteo F, Brakebusch C. Cdc42 expression in keratinocytes is required for the maintenance of the basement membrane in skin [J]. Matrix Biol, 2006, 25(8): 466-474.
[17] Troester MA, Lee MH, Carter M, et al. Activation of host wound responses in breast cancer microenvironment [J]. Clin Cancer Res, 2009, 15(22): 7020-7028.
[18] Castven D, Fischer M, Becker D, et al. Adverse genomic alterations and stemness features are induced by field cancerization in the microenvironment of hepatocellular carcinomas[J]. Oncotarget, 2017, 8(30): 48688-48700.
[19] Trujillo KA, Heaphy CM, Mai M, et al. Markers of fibrosis and epithelial to mesenchymal transition demonstrate field cancerization in histologically normal tissue adjacent to breast tumors [J]. Int J Cancer, 2011, 129(6): 1310-1321.
[20] Meriane M, Charrasse S, Comunale F, et al. Participation of small GTPases Rac1 and Cdc42Hs in myoblast transformation [J]. Oncogene, 2002, 21(18): 2901-2907.
[21] Qadir MI, Parveen A, Ali M. Cdc42: Role in cancer management [J]. Chem Biol Drug Des, 2015, 86(4): 432-439.
[22] Warner SJ, Yashiro H, Longmore GD. The Cdc42/Par6/aPKC polarity complex regulates apoptosis-induced compensatory proliferation in epithelia [J]. Curr Biol, 2010, 20(8): 677-686.
[23] Yamaguchi H, Lorenz M, Kempiak S, et al. Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2/3 complex pathway and cofilin [J]. J Cell Biol, 2005, 168(3): 441-452.
[24] Tsai CH, Chiu JH, Yang CW, et al. Molecular characteristics of recurrent triple-negative breast cancer [J]. Mol Med Rep, 2015, 12(5): 7326-7334.
[25] Chrysanthou E, Gorringe KL, Joseph C, et al. Phenotypic characterisation of breast cancer: the role of CDC42[J]. Breast Cancer Res Treat, 2017, 164(2): 317-325.
[26] Stengel K, Zheng Y. Cdc42 in oncogenic transformation, invasion, and tumorigenesis [J]. Cell Signal, 2011, 23(9): 1415-1423.
[27] Ma D, Cheng Y, Zhang Y, et al. Expression of CDC42 in cervical squamous cell carcinoma and its correlation with clinicopathologic characteristics [J]. Chin J Cancer Res, 2013, 25(6): 656-661.
[28] Halon A, Donizy P, Surowiak P, et al. ERM/Rho protein expression in ductal breast cancer: a 15 year follow-up[J]. Cell Oncol (Dordr), 2013, 36(3): 181-190.

Cdc42在舌鳞状细胞癌中的表达及临床意义

Expression of Cdc42 in tongue squamous cell carcinoma and its clinical significance

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	高嘉敏, 姚艳丽, 王玉珏, 张志愿, 孙树洋. 多西他赛对头颈鳞癌细胞焦亡的影响及作用机制探讨[J]. 中国口腔颌面外科杂志, 2023, 21(2): 105-111.
[2]	王俊安, 顾海林, 史文涛, 孙宇. 超声测量舌根至甲状软骨夹角预测喉镜暴露困难的临床研究[J]. 中国口腔颌面外科杂志, 2023, 21(2): 142-145.
[3]	柳江龙, 贾芳, 王晓荣, 热伊莱·阿不都克热木, 吾尔古丽·阿力甫, 买买提吐逊·吐尔地. 超声造影对口腔颌面部鳞癌颈部转移性淋巴结的诊断价值评价[J]. 中国口腔颌面外科杂志, 2023, 21(2): 168-174.
[4]	刘恒, 段晓峰. 铁自噬及相关基因NCOA4、FTH1在口腔鳞癌中的研究进展[J]. 中国口腔颌面外科杂志, 2023, 21(1): 87-91.
[5]	陈霖, 陈寅瑜, 丁紫雪, 孟箭. 以吞咽困难为首发症状的AL型舌淀粉样变合并多发性骨髓瘤1例报告[J]. 中国口腔颌面外科杂志, 2023, 21(1): 97-101.
[6]	席庆. 舌根肿瘤,开放手术还是机器人手术?[J]. 中国口腔颌面外科杂志, 2022, 20(6): 527-533.
[7]	杨慧丽, 王宇帆, 王锋, 沈月洪, 杨宏宇. NLRP1在头颈部鳞癌中的表达及预后意义[J]. 中国口腔颌面外科杂志, 2022, 20(5): 429-436.
[8]	吴梓谦, 殷玉兰, 杨文玉, 张贞, 侯黎莉, 王磊. 口腔癌患者术后舌神经功能障碍与生活质量的关系评价[J]. 中国口腔颌面外科杂志, 2022, 20(5): 449-454.
[9]	季萍萍, 李莉, 吴奕帆, 侯黎莉. 经皮穴位电刺激防治口腔鳞癌患者诱导化疗后骨髓抑制的效果观察[J]. 中国口腔颌面外科杂志, 2022, 20(5): 455-460.
[10]	许刚, 宋其义, 蒋卫东, 刘景秀. 水通道蛋白3在口腔鳞癌中的表达及临床意义[J]. 中国口腔颌面外科杂志, 2022, 20(5): 478-482.
[11]	汪冲, 康馨丹, 王瑞, 吴亚平, 孙露露, 张志愿, 孙树洋. 头颈鳞癌患者源性类器官模型的建立和鉴定[J]. 中国口腔颌面外科杂志, 2022, 20(4): 328-333.
[12]	赵小妹, 夏荣辉, 钟来平, 朱东旺, 张志愿. Nrf2对口腔鳞癌患者TPF诱导化疗效果的影响[J]. 中国口腔颌面外科杂志, 2022, 20(4): 366-370.
[13]	李恒勇, 杨宋, 周凯, 孔钰, 李洁莹, 李贵忠, 葛胜优, 杨小琛, 冯元勇, 宋凯, 尚伟. 336例HPV相关性与非相关性口咽鳞癌患者生存分析[J]. 中国口腔颌面外科杂志, 2022, 20(4): 378-383.
[14]	代晓彤, 张敬玲, 李珍, 马嫣然, 刘思宇, 徐晓雨, 卢恕来. 甲状舌管囊肿合并遗传性凝血因子V缺乏症1例报告[J]. 中国口腔颌面外科杂志, 2022, 20(4): 410-412.
[15]	张益益, 杨玥怡, 琚梧桐, 钟来平. 局部晚期口腔鳞癌新辅助免疫靶向治疗2例及文献复习[J]. 中国口腔颌面外科杂志, 2022, 20(4): 413-416.